Drug-Eluting Balloons

This channel includes news and new technology innovations for drug-coated balloons (DCB), also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis. The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia (scar tissue growth) caused by trauma when the vessel segment is treated for atherosclerotic lesions with balloon angioplasty. DCBs can be used to treat hyperplasia in arteriovenous (AV) access fistulae in dialysis patients, where the vessel undergoes repeated trauma from regular punctures. DCBs also are used to treat in-stent restenosis due to scar tissue proliferation inside stents, which can cause a vessel to occlude.

Feature | August 19, 2013

August 19, 2013 — Medtronic Inc. announced the submission of its first pre-market approval (PMA) module to the U.S....

News | July 01, 2013

July 1, 2013 — One-year data from an Italian multicenter randomized controlled trial of the In.Pact Falcon...

News | June 20, 2013

June 20, 2013 — Biosensors International Group Ltd. has entered into a licensing agreement with Eurocor GmbH, a...

Lutonix Drug Coated Balloon C. R. Bard Inc. PAD Treatments Clinical Trial
News | June 10, 2013

June 10, 2013 — C. R. Bard Inc. announced the enrollment of the first patient into the Lutonix Below the Knee (BTK...

News | February 11, 2013

February 11, 2013 — Vascular Nanotransfer Technologies (VNT) says it has developed the industry’s most versatile...

Top stories of 2012 in cardiology
Feature | January 29, 2013 | Dave Fornell

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click...

News | December 26, 2012

December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to...

Primus Drug-Eluting Balloon Balloon Catheters Peripheral Artery Disease devices
News | November 01, 2012

November 1, 2012 — It looks as though drug-...

Primus Drug-Eluting Balloon
News | September 21, 2012

September 21, 2012 — Cardionovum GmbH announced that the results of a preclinical study and a first-in-man clinical...

News | July 27, 2012

July 27, 2012 — C. R. Bard Inc. announced that its Lutonix technology center has completed patient enrollment into...

News | July 09, 2012

July 9, 2012 — Cardionovum GmbH announced it has initiated in vivo testing of its second...

News | June 13, 2012

June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials,...

Feature | April 17, 2012

April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the...

News | March 20, 2012

March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked...

Overlay Init